| Benedict Maliakkal, MD | |
|
1265 Union Ave, Suite 184, Memphis, TN 38104-3415 | |
| (901) 516-9183 | |
| (901) 516-8993 |
| Full Name | Benedict Maliakkal |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 40 Years |
| Location | 1265 Union Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306872155 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metro Nashville General Hospital | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metropolitan Hospital Authority | 3779775432 | 43 |
News Archive
Universal decolonization of all patients admitted to intensive care units using chlorhexidine baths and mupirocin treatment for 5 days significantly reduces the risk for infection with methicillin-resistant Staphylococcus aureus , report researchers.
The plan is an early-warning ranking system similar to that deployed at times of hurricanes and is intended to protect and mobilize the country against a flu pandemic.
In a preview of a Jan. 24 magazine article, The New York Times reports on Senate Majority Leader Harry Reid's struggle to keep members of his caucus in line on health reform. In December, for instance, Sen. Joseph Lieberman, D-Conn., told a talk show host he would not support the health overhaul plan without significant changes, surprising the majority leader.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 7 days ago
| Entity Name | Saint Thomas Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437194669 PECOS PAC ID: 1557269354 Enrollment ID: O20031230000470 |
News Archive
Universal decolonization of all patients admitted to intensive care units using chlorhexidine baths and mupirocin treatment for 5 days significantly reduces the risk for infection with methicillin-resistant Staphylococcus aureus , report researchers.
The plan is an early-warning ranking system similar to that deployed at times of hurricanes and is intended to protect and mobilize the country against a flu pandemic.
In a preview of a Jan. 24 magazine article, The New York Times reports on Senate Majority Leader Harry Reid's struggle to keep members of his caucus in line on health reform. In December, for instance, Sen. Joseph Lieberman, D-Conn., told a talk show host he would not support the health overhaul plan without significant changes, surprising the majority leader.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 7 days ago
| Entity Name | Metropolitan Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710206156 PECOS PAC ID: 3779775432 Enrollment ID: O20101013000530 |
News Archive
Universal decolonization of all patients admitted to intensive care units using chlorhexidine baths and mupirocin treatment for 5 days significantly reduces the risk for infection with methicillin-resistant Staphylococcus aureus , report researchers.
The plan is an early-warning ranking system similar to that deployed at times of hurricanes and is intended to protect and mobilize the country against a flu pandemic.
In a preview of a Jan. 24 magazine article, The New York Times reports on Senate Majority Leader Harry Reid's struggle to keep members of his caucus in line on health reform. In December, for instance, Sen. Joseph Lieberman, D-Conn., told a talk show host he would not support the health overhaul plan without significant changes, surprising the majority leader.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benedict Maliakkal, MD Po Box 1000, Dept 457, Memphis, TN 38148-0001 Ph: (901) 275-3662 | Benedict Maliakkal, MD 1265 Union Ave, Suite 184, Memphis, TN 38104-3415 Ph: (901) 516-9183 |
News Archive
Universal decolonization of all patients admitted to intensive care units using chlorhexidine baths and mupirocin treatment for 5 days significantly reduces the risk for infection with methicillin-resistant Staphylococcus aureus , report researchers.
The plan is an early-warning ranking system similar to that deployed at times of hurricanes and is intended to protect and mobilize the country against a flu pandemic.
In a preview of a Jan. 24 magazine article, The New York Times reports on Senate Majority Leader Harry Reid's struggle to keep members of his caucus in line on health reform. In December, for instance, Sen. Joseph Lieberman, D-Conn., told a talk show host he would not support the health overhaul plan without significant changes, surprising the majority leader.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
› Verified 7 days ago
Khawaja Muhammad Muddassir, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave, Suite 370, Memphis, TN 38104 Phone: 901-758-7888 Fax: 901-387-5153 | |
Dr. Jordan Redfield, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 920 Madison Ave Ste 447, Memphis, TN 38103 Phone: 901-448-5814 | |
Allison Montague, Gastroenterology Medicare: Medicare Enrolled Practice Location: 1955 S 3rd St, Memphis, TN 38109 Phone: 901-515-5800 | |
Dr. Marcia Bradford, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 360 E Eh Crump Blvd, Memphis, TN 38126 Phone: 901-261-2000 Fax: 901-946-9262 | |
Dr. Aleksandar Jankov, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd, Suite 301, Memphis, TN 38120 Phone: 901-747-9081 Fax: 901-747-9087 | |
Manoj K Jain, MD, MPH Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd Ste 209, Memphis, TN 38120 Phone: 901-681-0778 Fax: 901-821-9987 | |
Dr. Karl Weber, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-4739 |